AVGR (Avinger Inc.) Return on Sales by Gross Profit

Gross margin deviation demonstrates the effectiveness of Avinger, Inc. (AVGR) patents for catheter nano-visualization. However, the 20.90 level reflects the current state amid stringent regulatory requirements and litigation risks. The situation is further complicated by aggressive pricing pressure from industry behemoths, leading to a reduction in the manufacturer's market share within the vascular therapy segment.
Comprehensive metric breakdowns and analytics for Avinger, Inc. (AVGR)

Avinger, Inc. (AVGR) is a promising asset due to its status as a cardiology innovator, with its valuation depending on the effective monetization of its unique OCT catheters. This metric measures the profit margin after deducting direct production costs, demonstrating the company's ability to control the cost of high-tech equipment. By analyzing the gross margin, an investor assesses real operational efficiency and capital stability amid the implementation of breakthrough vascular imaging methods.